Deltex Medical Group Plc (DEMG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 52 | 404 | 447 | 141 | 329 |
| Other Working Capital | -605 | 460 | 46 | 1,010 | 649 |
| Other Operating Activity | -765 | -1,792 | -2,309 | -2,839 | -2,781 |
| Operating Cash Flow | $-1,318 | $-928 | $-1,816 | $-1,688 | $-1,803 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -6 | -26 | -68 | -372 |
| Other Investing Activity | -196 | -286 | -532 | -407 | -463 |
| Investing Cash Flow | $-214 | $-292 | $-558 | $-475 | $-835 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -171 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 0 | 1,125 | N/A | 0 |
| Debt Repayment | N/A | -7 | -1,109 | -226 | -187 |
| Common Stock Issued | 2,216 | 952 | 2,508 | 59 | 4,566 |
| Other Financing Activity | -168 | -75 | -197 | -34 | -278 |
| Financing Cash Flow | $1,877 | $870 | $2,327 | $-201 | $4,101 |
| Exchange Rate Effect | 16 | -13 | 54 | 5 | 12 |
| Beginning Cash Position | 219 | 582 | 575 | 2,934 | 1,459 |
| End Cash Position | 580 | 219 | 582 | 575 | 2,934 |
| Net Cash Flow | $345 | $-350 | $-47 | $-2,364 | $1,463 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,318 | -928 | -1,816 | -1,688 | -1,803 |
| Capital Expenditure | -232 | -292 | -559 | -476 | -837 |
| Free Cash Flow | -1,550 | -1,220 | -2,375 | -2,164 | -2,640 |